While California has some of the strictest vaccine laws in the country, conservative Shasta County’s approach during the COVID pandemic stood in stark contrast with the state’s guidance.

The court cited threats to Kenyan lives and barred entrance to the country to anyone from Ebola-affected regions ...

The combination regimen significantly improved progression-free survival and objective response rates in patients who were intolerant to or failed prior imatinib therapy ...

The 3-month extension follows a major amendment to the NDA for the intrathecal cyclodextrin-based therapy, which has shown a 71% reduction in mortality risk in clinical trials.

Backed by the phase 2b/3 EPICS-III trial, saroglitazar demonstrated a significant 56.7% biochemical response rate compared with 9.8% for placebo, while showing favorable safety data.

Tirzepatide is superior to intensified conventional care (ICC) for adults with early type 2 diabetes (T2D) uncontrolled with metformin, according to a study pub ...

Investigational oral substrate therapy BBP-418 demonstrated significant increases in alpha-dystroglycan glycosylation and improved ambulatory function in the phase 3 FORTIFY interim analysis.

Guselkumab was associated with significant inhibition of structural joint damage in adults with active psoriatic arthritis. The Food and Drug Administration (FDA) has approved updated labeling for ...

Researchers found that the ferritin curve inflection for ID occurred at 23.9µg/L with hemoglobin and 25.0µg/L with erythrocyte zinc protoporphyrin. HealthDay News — Physiologically based ferritin ...

The Trump administration has issued a directive shutting key US health research officials out of global discussions on virus outbreaks, according to CNN. Specifically, officials from the National ...

An ongoing phase 2 trial is assessing the efficacy of elunetirom for adults with bipolar depression taking a mood stabilizer.

A second opinion physician was held liable for an unnecessary hysterectomy despite a laboratory mix-up at the original facility.